Alerts will be sent to your verified email
Verify EmailGENNEX
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Gennex Laboratories Ltd specializes in the production and export of bulk drugs and intermediates such as Guaiphenesin, Methocarbamol, Fluconazole, and Phenazopyridine.
Gennex Lab major competitors are Zim Laboratories, Trident Lifeline, Brooks Laboratories, Vaidya Sane Ayur Lab, Lyka Labs, Albert David, Ambalal Sarabhai Ent.
Market Cap of Gennex Lab is ₹328 Crs.
While the median market cap of its peers are ₹293 Crs.
Gennex Lab seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.